Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non nucleoside reverse transcriptase inhibitors

Non nucleoside reverse transcriptase inhibitors

US Patent 7462608 · Granted Dec 9, 2008

Estimated economic value: $178,583,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adenosine derivative and pharmaceutical composition comprising the same2025
Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, an2025
Adenosine derivative and pharmaceutical composition comprising the same2025
System and method for extracting carbon dioxide from atmospheric air via pressur2025
Combination therapy for HIV with adenosine derivative and capsid inhibitors2025
Inhibitors of peptidylarginine deiminases2025
Heterocyclic carboxylate compounds as glycolate oxidase inhibitors2024
System and method for extracting carbon dioxide from atmospheric air via pressur2024
Combination therapy for HIV with adenosine derivative and capsid inhibitors2024
Inhibitors of peptidylarginine deiminases2024
Heterocyclic carboxylate compounds as glycolate oxidase inhibitors2023
Adenosine derivative and pharmaceutical composition comprising the same2023